Throughout decades of estrogen research on CVDs, several studies have demonstrated that endothelial ERα participates in E2-mediated effects against atherosclerosis in low-density lipoprotein (LDL) receptor-deficient mice (Billon-Galés et al., 2009). The gene discussed is ESR1; the disease is atherosclerosis.